Taysha Gene Therapies, Inc. (TSHA) Earnings
NASDAQ·Healthcare·Biotechnology
$4.26
+6.23%
Mkt Cap $1.29B
EPS — Estimate vs Actual
Mkt Cap
$1.29B
P/E
—
Fwd P/E
—
P/S
172.19
Rev TTM
—
EPS TTM
-$0.38
NASDAQ·Healthcare·Biotechnology
$4.26
+6.23%
Mkt Cap $1.29B
Mkt Cap
$1.29B
P/E
—
Fwd P/E
—
P/S
172.19
Rev TTM
—
EPS TTM
-$0.38